Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Crown ElectroKinetics | CRKN | Nov 29, 2024 | 0.28 | +0.32 |
Crown Holdings | CCK | Nov 29, 2024 | 92.09 | -1.00 |
Crown LNG | CGBS | Nov 29, 2024 | 0.31 | -3.74 |
Cryo-Cell International | CCEL | Nov 29, 2024 | 8.67 | -4.62 |
CryoPort | CYRX | Nov 29, 2024 | 7.08 | -0.14 |
CS Disco | LAW | Nov 29, 2024 | 5.92 | +0.68 |
CSG Systems International | CSGS | Nov 29, 2024 | 54.81 | +0.40 |
CSP | CSPI | Nov 29, 2024 | 16.25 | +2.72 |
CSW Industrials | CSWI | Nov 29, 2024 | 422.39 | +1.24 |
CSX | CSX | Nov 29, 2024 | 36.55 | -0.08 |
CTO Realty Growth | CTO | Nov 29, 2024 | 20.41 | -0.15 |
CTO Realty Growth A Pref | CTO-A | Nov 29, 2024 | 23.65 | +0.49 |
CTS | CTS | Nov 29, 2024 | 54.91 | +1.07 |
CubeSmart | CUBE | Nov 29, 2024 | 49.56 | -1.16 |
Cue Biopharma | CUE | Nov 29, 2024 | 1.22 | 0.00 |
Cullen Frost Bankers B Pref | CFR-B | Nov 29, 2024 | 19.40 | -1.22 |
Cullen/Frost Bankers | CFR | Nov 29, 2024 | 140.62 | -1.24 |
Cullinan Therapeutics | CGEM | Nov 29, 2024 | 13.45 | +2.75 |
Cullman Bancorp | CULL | Nov 29, 2024 | 9.71 | 0.00 |
Culp | CULP | Nov 29, 2024 | 5.25 | +1.35 |
Cumberland Pharmaceuticals | CPIX | Nov 29, 2024 | 1.40 | +2.19 |
Cummins | CMI | Nov 29, 2024 | 375.04 | +1.08 |
Cumulus Media A | CMLS | Nov 29, 2024 | 0.78 | +2.02 |
Curbline Properties | CURB | Nov 29, 2024 | 24.26 | 0.00 |
Curevac N.V. | CVAC | Nov 29, 2024 | 2.87 | 0.00 |
CuriosityStream | CURI | Nov 29, 2024 | 1.83 | 0.00 |
Curis | CRIS | Nov 29, 2024 | 4.39 | -1.35 |
CURRENC Group | CURR | Nov 29, 2024 | 1.79 | 0.00 |
Curtiss-Wright | CW | Nov 29, 2024 | 373.63 | +0.61 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Nov 29, 2024 | 46.50 | +2.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.